result of other cardiorespiratory problems, such as heart failure, chronic obstructive pulmonary disease, pulmonary embolism, and be as a result of hypostasis related to atelectasis in dependant parts of the lung. An acute phase response with fever, leukocytosis, and elevated C-reactive protein concentrations frequently occurs without infection; 13 fever may also be masked by antiplatelet (aspirin) and paracetamol use. Even chest radiography, a central component of diagnostic criteria, may have limited utility in the early stages because infiltrates may not be present. 14 Further, reduced voluntary deep inspiration and impaired diaphragmatic excursion on the affected side of the thorax may affect the quality of the chest radiography. 15, 16 In a recent survey of practice in German stroke units, fever and severe stroke were the clinical factors that mainly influenced the clinician diagnosis of pneumonia, although variability in the diagnostic approach was clearly apparent. 8 There are currently no agreed gold standard or reference standards for diagnosis of pneumonia in stroke unit care, and various terminologies are used to describe the spectrum of lower respiratory tract infections complicating stroke. To address these issues, we convened a multidisciplinary group (Pneumonia in Stroke Consensus Group) to develop evidence and consensus-based operational criteria for standardized terminology and operational diagnostic criteria for the spectrum of lower respiratory tract infections complicating stroke. As a first step, we undertook a systematic review to identify the existing diagnostic approaches to pneumonia in recent clinical stroke research to establish the variation in diagnostic approach and terminology. Where standard criteria (published respiratory or other societal criteria) had been applied, we sought to quantify the heterogeneity in reported occurrence of pneumonia using meta-analysis and to explore possible reasons for this heterogeneity.
Methods

Search Method and Data Extraction
A systematic literature review was undertaken in accordance with Center for Reviews and Dissemination and Cochrane Collaboration guidance. 17 Searches were undertaken in multiple electronic databases using predefined search criteria and terms (Table I in the onlineonly Data Supplement). Published studies of hospitalized adults with ischemic stroke, intracerebral hemorrhage (ICH), or both, which reported occurrence of pneumonia from 1st January 2009 to 1st March 2014, were independently screened for eligibility (Table II in the online-only Data Supplement) by 2 reviewers (A.K. Kishore and C.J. Smith) using the study title and abstract. We restricted searches to the preceding 5 years to provide relatively recent context and avoid potentially obsolete diagnostic approaches or criteria. Prospective or retrospective observational studies or randomized-controlled trials in English language were considered. Studies involving patients <18 years, exclusively intubated and ventilated patients or studies including patients with preexisting pneumonia, were excluded.
Lead or corresponding authors of studies under consideration were contacted by e-mail to resolve issues relating to assessment of eligibility or data extraction. Discrepancies relating to eligibility or data extraction were resolved by discussion between the same 2 study investigators. Data extracted included study design, stroke subtype (ischemic stroke or ICH), mean age, mean National Institutes of Health Stroke Scale score, terminology and criteria used in the diagnosis of pneumonia, clinical environment, country, and the proportion of patients with pneumonia (Table III in the onlineonly Data Supplement) .
Statistical Analyses
The primary analysis was frequency of the different diagnostic categories or approaches to pneumonia identified. Random effects metaanalysis for proportions was performed using Stats Direct software (v 2.7.9, 2012). Heterogeneity was quantified using the I 2 statistic. The identification of both objective (eg, Centers for Disease Control and Prevention [CDC] criteria) and nonobjective (eg, unspecified clinician diagnosis) approaches to pneumonia diagnosis was anticipated. To explore possible reasons for heterogeneity where standard objective criteria (existing published respiratory/other societal diagnostic criteria) had been applied for diagnosis, secondary analyses were stratified by selectivity (classified as unselected or selected population, ie, studies with particular high risk clinical characteristics for pneumonia, eg, dysphagia studies, intensive care unit studies); stroke type-ischemic, hemorrhagic or both; age; duration from stroke onset to recruitment; duration observed for occurrence of pneumonia.
Results
Study and Prticipant Characteristics
Sixty-four studies (56% ischemic stroke, 6% ICH, 38% both) of 639 953 patients were included ( Figure I and Table III in the online-only Data Supplement). The majority of studies were retrospective (61%). 38% of the studies were performed in Europe, 28% in South East Asia/Asia Pacific region, and 22% in United States. The rest were performed in Chile, Nigeria, Mexico, and Canada. Studies were conducted on the acute stroke unit in 44%, whereas the setting was unclear in 28% of studies. Other clinical environments where studies were conducted included acute admissions units, emergency admissions units, medical wards, rehabilitation wards, and intensive care units. The mean age of the included participants was 71 years (SD 6.6; range 44-84.6 years) and was reported in 95% of studies. Stroke severity, most often the National Institutes of Health Stroke Scale (93%; mean 9 [SD 3.2]), was reported in only 47% of studies. Other stroke severity scales used were the Canadian Neurological Stroke scale and the Scandinavian Stroke Scale.
Variation in the Terminology and Diagnostic Approach
Terminology with respect to pneumonia varied: 52% of studies used pneumonia, 14% used stroke-associated pneumonia, and another 14% used aspiration pneumonia. Other terms included post-stroke pneumonia, hospital-acquired pneumonia, and chest infection.
Three main diagnostic approaches to pneumonia were identified: (1) objective standard criteria based on previously published or respiratory/infectious diseases societal criteria or guidelines (20 studies, 31%); (2) ad hoc objective criteria, not previously published (26 studies, 41%); (3) unspecified clinician-reported diagnosis or initiation of antibiotics (12 studies, 19%) . No definition or diagnostic approach was reported or available after contacting corresponding authors in the final 6 studies (9%). Of studies using objective standard criteria (Tables 1 and 2 ), the majority used CDC criteria (75%) followed by Mann criteria (20%) 18 and American Thoracic Society and Infectious Diseases Society of America (5%). 19 A description of how clinicians applied the standardized criteria, including clinical specialty, training received, or whether diagnosis was adjudicated, was reported in only 10%. The frequency of symptoms, signs, and investigations used in
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the studies providing ad hoc objective diagnostic criteria are presented in Figure 1 . An abnormal chest x-ray was the most frequent criterion included (76.6%) and was the only mandatory criterion in 38% of studies. ).
Occurrence of Pneumonia
Heterogeneity Assessment
Although substantial heterogeneity was anticipated among studies without objective criteria, comparable heterogeneity was also observed among studies that used standard criteria (Table 3) . In secondary analyses, pneumonia occurred more frequently in the selected high-risk (35.9%; 95% CI 25.8%-47.8%; I 2 =93.8%) than unselected (13.4%; 95% CI 9.8%-17.5%; I 2 =98.5%) studies as expected, again with marked heterogeneity within each subgroup ( Figure 2 ; Table IV in the online-only Data Supplement). Substantial heterogeneity among subgroups remained even when only the most frequently used (CDC) criteria were considered (18.2%; 95% CI 13.8%-23%; I 2 =98.7%) and even when restricted to unselected participants (13.5%; 95% CI 9.7%-17.8%; I 2 =98.6%). Mean age (range 66-77.6 years) did not explain the substantial heterogeneity with higher occurrence of pneumonia seen in some studies with younger mean age ( Figure 2 ). Substantial heterogeneity was again noted when analysis was restricted to stroke (Table III in the online-only Data Supplement). Only 50% of studies recorded duration of observation for reporting occurrence of pneumonia, thus limiting interpretation of data to explain heterogeneity. Where reported, duration of follow-up varied from 5 days to 3 months, with limited data suggesting that a large proportion (63%-73%) of pneumonia occurred within 72 hours.
30,38
Discussion
We found that the approach to diagnosis and terminology of pneumonia was highly variable in recent clinical stroke research. Around 9% of studies reported no information or criteria for diagnosis of pneumonia, and other study characteristics (baseline stroke severity, clinical environment, duration of follow-up for reporting pneumonia) were insufficiently reported overall. The majority of studies used objective but ad hoc, previously unpublished diagnostic criteria, which varied considerably between studies. Typical chest x-ray abnormalities, a cornerstone of diagnosis in communityacquired pneumonia and hospital-acquired pneumonia, were rarely mandatory and the justification of thresholds for some parameters, for example, for C-reactive protein concentrations, uncertain. Most of the studies which applied standard diagnostic approaches used the CDC criteria, which were developed for hospital-acquired pneumonia, and include a mandatory requirement for new infiltrate on chest x-ray. 5 The Mann criteria, originally described in a study of dysphagic stroke patients, 18 were used relatively infrequently by comparison. Although the CDC and Mann criteria are broadly comparable, they differ in the CDC requirement of mandatory chest x-ray appearances and optional leukocytosis/leukopenia and the optional identification of a relevant pathogen in the Mann criteria. For the majority of studies applying objective diagnostic criteria, it was unclear by whom the criteria were applied, what training had been provided, and whether the diagnoses (or chest x-ray findings) were independently adjudicated. Furthermore, sensitivity or specificity of particular clinical symptoms, signs, or investigations for a confirmed diagnosis of pneumonia was not reported in any of the studies, for any diagnostic approaches or criteria. To our knowledge, none of these objective criteria have been validated in patients with stroke.
The overall occurrence of pneumonia in the present review (14.3%) was higher than reported in a previous systematic review and meta-analysis (10%). 81 This most likely relates to inclusion of different studies conducted over differing time periods, varying eligibility criteria among included studies, and marked heterogeneity between studies reported in both reviews. Diagnostic criteria were not reported for the studies included in the previous review, 81 although the likely influence on heterogeneity was acknowledged.
Perhaps an unexpected finding of our study was that occurrence of pneumonia was highest in the studies applying objective standard criteria compared with those studies using individual clinician-based diagnosis (including 
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clinician initiation of antibiotics) or no reported definition of pneumonia. Substantial heterogeneity was observed even in the studies using standard criteria, which was not apparently explained by stratifying for other potential confounders in secondary analyses. The majority of high-risk studies using Mann criteria were dysphagia assessment studies, and population size was relatively small, limiting interpretation. Substantial heterogeneity was also seen in both selected and unselected studies using the CDC criteria. It is possible that variation in the application of the CDC criteria, including interpretation of chest x-ray findings, may contribute to the observed heterogeneity. In a prospective study of patients with ICH and subarachnoid hemorrhage, inter-rater reliability between clinicians applying the CDC criteria for pneumonia was poor (ĸ=0.30). 83 The lack of standardized diagnostic criteria for lower respiratory tract infections complicating stroke and the variation in diagnostic approach has significant implications in clinical practice and research. In clinical practice, it influences clinical decision-making regarding appropriate use of antibiotics (timing and clinician thresholds for antibiotic initiation), diagnostic uncertainty (consideration of other differential diagnoses), and prognostication. It also affects studies evaluating pneumonia risk-stratification or those evaluating pneumonia as an outcome/end point (epidemiological studies; studies of preventive research interventions, eg, prophylactic antibiotics, interventions for dysphagia).
We acknowledge that our study has several limitations. Inclusion of non-English articles may have retrieved additional relevant information from non-English speaking countries. Despite this, our study included a broad range of countries, including the Asia-Pacific region, South America, and Africa. Likewise, exclusion of published abstracts without a full-text publication may have missed potentially relevant data. However, in our opinion, identification of additional studies would not have altered our findings of marked inconsistencies in reported frequencies of pneumonia. We did not include studies earlier than 2009 because we planned to review diagnostic approaches to pneumonia in relatively recent clinical stroke research, to provide current context, and avoid potentially obsolete diagnostic approaches or criteria. However, we accept that although the cut-off of 2009 is arbitrary, it was concordant with our aims, and it is uncertain how inclusion of studies from preceding years would add to our overall findings and conclusions. A limitation of our analyses was the incomplete reporting of study characteristics between studies. For example, stroke severity was reported in only around 50%, and the length of surveillance period for pneumonia in <50%. It is also likely that variation existed even in the application of the objective standard criteria (eg, CDC), although insufficient data were available. Conclusions regarding how much heterogeneity between studies related to study characteristics, and how much to the diagnostic approach, were therefore limited. We also excluded studies which only included ventilated stroke patients. We think this is justified because diagnosis of ventilator-associated pneumonia in stroke patients poses distinct challenges when compared with the acute stroke unit setting, and various guidelines for ventilator-associated pneumonia are already in existence.
Conclusions
Our review highlights the considerable variation in terminology, approach, and criteria for diagnosing pneumonia in recent clinical stroke research. Although the majority of studies used some form of objective criteria, these were generally ad hoc and varied between studies. Even the use of standard Figure 2 . Forest plot of objective standard diagnostic criteria (n=19 studies; in order of increasing mean age). One study in the objective standard category was excluded from analyses as patients were selected but not perceived high-risk (Scheitz et al 82 ). ATSIDS indicates American Thoracic Society and Infectious Diseases Society; CDC, Centers for Disease Control and Prevention; and NR, not reported. #Ji et al 29 reported on 3 cohorts in a single publication.
by guest on January 27, 2018 http://stroke.ahajournals.org/ Downloaded from criteria in unselected patients was associated with substantial heterogeneity between studies in the reported occurrence of pneumonia. These findings warrant the development of consensus-based, operational criteria for terminology and diagnostic approach to the spectrum of lower respiratory tract infections in stroke unit care.
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